<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Res Pharm Pract</journal-id><journal-id journal-id-type="iso-abbrev">J Res Pharm Pract</journal-id><journal-id journal-id-type="publisher-id">JRPP</journal-id><journal-title-group><journal-title>Journal of Research in Pharmacy Practice</journal-title></journal-title-group><issn pub-type="ppub">2319-9644</issn><issn pub-type="epub">2279-042X</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6121759</article-id><article-id pub-id-type="publisher-id">JRPP-7-168</article-id><article-id pub-id-type="doi">10.4103/jrpp.JRPP_18_12</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>A Newly Proposed Management Protocol for Acute Aluminum Phosphide Poisoning</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dorooshi</surname><given-names>Gholamali</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Zoofaghari</surname><given-names>Shafeajafar</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mood</surname><given-names>Nastaran Eizadi</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gheshlaghi</surname><given-names>Farzad</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Clinical Toxicology, Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</aff><author-notes><corresp id="cor1"><bold><italic>Address for correspondence:</italic></bold> Dr. Gholamali Dorooshi, E-mail: <email xlink:href="gdorvashy@med.mui.ac.ir">gdorvashy@med.mui.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2018</year></pub-date><volume>7</volume><issue>3</issue><fpage>168</fpage><lpage>169</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2018 Journal of Research in Pharmacy Practice</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0"><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Dear Editor,</p><p>Aluminum phosphide (ALP) which is locally called rice tablet is a known fumigant used in grain storage facilities with a greenish&#x02013;gray tablet that has a rotten fish or garlic odor.[<xref rid="ref1" ref-type="bibr">1</xref>] Rice tablets contain ALP, urea, and ammonium carbamate, which through contact with water, steam, and gastric acid produce phosphine gas (PH<sub>3</sub>). Phosphine gas is highly toxic, flammable, and is a protoplasmic poison.[<xref rid="ref1" ref-type="bibr">1</xref>]</p><p>Ingestion of 500 mg of ALP can be fatal in an adult and its LD50 is 10 mg/kg. (Each ALP tablet liberates up to 1 g of PH<sub>3</sub>.) The mortality rate following metal phosphide ingestion is 31%&#x02013;77%. Most of the deaths are due to cardiovascular collapse, refractory shock, severe acidemia, fulminant hepatic failure, and adult respiratory distress syndrome.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref>]</p><p>All ALP exposures should be treated as potentially life-threatening. Management should be rapidly initiated based on a history and clinical examination and should not be delayed for the confirmatory diagnosis. Due to the lack of an antidote, the treatment has already included symptomatic and supportive treatments.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Many medical interventions have been proposed for the treatment of patients with acute ALP poisoning, but data supporting their efficacy are lacking. Many publications report concurrent administration of a number of therapies in the hope of a benefit.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>]</p><p>The efficacies of these therapeutic methods remain uncertain and the outcome of ALP poisoning is still disappointing, with a high mortality. Unfortunately, due to the high toxicity, low cost, and availability, ALP causes a lot of intentional and accidental poisoning and, as a result, many deaths in Iran.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Due to the lack of a single therapeutic guideline with a clinically acceptable efficacy for the treatment of ALP poisonings, the Department of Clinical Toxicology of Noor University Hospital (Affiliated with the School of Medicine at Isfahan University of Medical Sciences, Isfahan, Iran) has recently proposed and developed a new therapeutic approach, which is now under clinical evaluation in a registered and ethically approved clinical study that its components have been investigated in some separate previously published studies. In our study, the efficacy and safety of this newly proposed management/treatment protocol are compared with the standard supportive care which is recommended by the relevant medical textbook.[<xref rid="ref1" ref-type="bibr">1</xref>]</p><p>The components of the newly proposed management/treatment protocol are gastric evacuation, castor oil, calcium gluconate, magnesium sulfate, albumin, hyperinsulinemia&#x02013;euglycemia therapy, amiodarone, sodium bicarbonate, N-acetyl salicylic acid, Vitamin C (acsorbic acid), Vitamin E, methylene blue, coenzyme Q-10, silymarin, curcuma, and pralidoxime.</p><p>According to our plan, this study will approach its aims gradually (due to small number available poisoned cases) and the final results of it will be published within the next 2 years.</p><sec disp-level="2" id="sec2-1"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec disp-level="2" id="sec2-2" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></body><back><ref-list><title>R<sc>EFERENCES</sc></title><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>RS</given-names></name><name><surname>Howland</surname><given-names>MA</given-names></name><name><surname>Lewin</surname><given-names>NA</given-names></name><name><surname>Nelson</surname><given-names>LS</given-names></name><name><surname>Goldfrank</surname><given-names>LR</given-names></name></person-group><source>Goldfrank's Toxicologic Emergencies</source><year>2015</year><edition>10th ed</edition><publisher-loc>New York</publisher-loc><publisher-name>McGraw-Hill Companies</publisher-name><fpage>1381</fpage><lpage>2</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurjar</surname><given-names>M</given-names></name><name><surname>Baronia</surname><given-names>AK</given-names></name><name><surname>Azim</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>K</given-names></name></person-group><article-title>Managing aluminum phosphide poisonings</article-title><source>J Emerg Trauma Shock</source><year>2011</year><volume>4</volume><fpage>378</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">21887030</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehrpour</surname><given-names>O</given-names></name><name><surname>Jafarzadeh</surname><given-names>M</given-names></name><name><surname>Abdollahi</surname><given-names>M</given-names></name></person-group><article-title>A systematic review of aluminium phosphide poisoning</article-title><source>Arh Hig Rada Toksikol</source><year>2012</year><volume>63</volume><fpage>61</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">22450207</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>R</given-names></name><name><surname>Binukumar</surname><given-names>BK</given-names></name><name><surname>Gill</surname><given-names>KD</given-names></name></person-group><article-title>Aluminum phosphide poisoning: An unsolved riddle</article-title><source>J Appl Toxicol</source><year>2011</year><volume>31</volume><fpage>499</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">21607993</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farahani</surname><given-names>MV</given-names></name><name><surname>Soroosh</surname><given-names>D</given-names></name><name><surname>Marashi</surname><given-names>SM</given-names></name></person-group><article-title>Thoughts on the current management of acute aluminum phosphide toxicity and proposals for therapy: An evidence-based review</article-title><source>Indian J Crit Care Med</source><year>2016</year><volume>20</volume><fpage>724</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">28149031</pub-id></element-citation></ref></ref-list></back></article>